Further Notifications

Here you find all press releases and further notifications, as well as all events of Fraunhofer ITMP.

News / 15.2.2023

Podcast on the "4D Clinic - Interdisciplinary Help for People with Immune Diseases"

Immune diseases, such as rheumatism or psoriasis, are systemic diseases that often affect several organ systems simultaneously. An interdisciplinary approach is absolutely necessary for the optimal care of patients. This is implemented at Fraunhofer ITMP in the concept of the 4D Clinic. Professor Frank Behrens, deputy director of the institute, describes in the Fraunhofer podcast why the 4D Clinic is unique and what the concept can achieve for patients and research.

Press Release / 11.2.2023

A potential oral therapy to treat hereditary angioedema

Hereditary angioedema (HAE) is a disorder in which one or more parts of the body become swollen. The triggers for HAE are unknown and is life threatening disorder, especially when the upper respiratory tract is affected. Current treatments for HAE include injections and infusions. In a Phase 2 clinical being run at the Universitätsklinikum Frankfurt, Charité - Universitätsmedizin Berlin and the Fraunhofer ITMP, it has been shown for the first time that an orally administered drug is effective against HAE. This therapy has the potential to overcome the issues relating the complicated route of administration for injections as well reduced cost.

News / 14.10.2022

Successful first round of the »TheraNova« Summer School

The first Summer School of the Innovation Center »Innovative Therapeutics« (TheraNova) took place in Mainz, October 13 to October 14, 2022. Project updates were given by participating PhD students and clinician scientists from Johann Wolfgang Goethe University and the Fraunhofer Institutes ITMP and IGD, and invited speakers highlighted current developments in the fields of innovative therapeutics, personalized medicine and entrepreneurship.

Research Divisions

Fraunhofer ITMP is organized in 3 cross-site research divisions.


Drug Discovery


From target to screening to lead optimization and formulation.


Preclinical Research


Translational cycles and OMICs analyses for characterization of biological mechanisms and novel targets.


Clinical Research


From „Proof-of-Concept“ to the characterization of established products: “Quality by Design” for successful translation of innovative ideas.

Innovation Areas

Fraunhofer ITMP is optimally interconnected internally as well as externally with other Fraunhofer institutes, universities and industry via the innovation areas. This is the prerequisite for transdisciplinary and flexible cooperation in the areas of new technologies, disease and treatment concepts.

Institute Locations


Locations of Fraunhofer ITMP


Fraunhofer ITMP, with its headquarters in Frankfurt am Main, currently has four additional institute locations in Hamburg, Göttingen, Berlin and Penzberg/Munich.


Headquarters of Fraunhofer ITMP

Frankfurt am Main


The site has strong expertise in pharmacology and clinical trials in immune-mediated diseases and pain. 


Discovery Research ScreeningPort



The site has strong expertise in high-throughput drug discovery (in silico, in vitro screening and drug repurposing) as well as a broad offering in "medical data science".


Translational Neuroinflammation and Automated Microscopy TNM


The site has strong expertise in high- and super-resolution microscopy techniques; as well as neuroinflammation and degenerative diseases.


Immunology and Allergology IA


The site has strong expertise in dermatology, allergology, and immunological mast cell-mediated inflammatory diseases of the skin.


Immunology, Infection and Pandemic Research IIP


The site has strong expertise in developing interventions to address the outbreak of new and spread of existing infectious diseases.